June 2022 // Communication


Read about our success story in an article published by NCCR Transcure


In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story. Prof. Jürg Gertsch together with our CEO Andrea Chicca, illustrate the path that led to the conception and launch of Synendos Therapeutics, a spin-off of NCCR TransCure and University of Bern. Read the full article here:


https://www.nccr-transcure.ch/communication/newsletter/newsletter-no-17/synendos-therapeutics

 


 

Recent Posts

See All

Lichtsteiner Foundation Testimonial Film about Synendos We are delighted to share the testimonial film created by the Lichtsteiner Foundation. Co-founder and CEO Andrea Chicca gives insights into entr

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity. The arti